Stocks
Ligand Pharmaceuticals IncorporatedLGND
NASDAQHealthcareBiotechnology$202.91-4.05%
A biotechnology company focused on acquiring or developing drug candidates and licensing them to pharmaceutical partners in exchange for milestone payments and royalties. Its portfolio includes technologies such as Captisol drug formulation and OmniAb antibody discovery platforms, which are used by ...
Market Cap: $4.0B52W Range: $93.58 – $227.92
Congressional Interest in Ligand Pharmaceuticals Incorporated (LGND)
2 members of Congress have disclosed 5 trades in Ligand Pharmaceuticals Incorporated (LGND), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
2
Sells
3
Who in Congress Is Trading LGND?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-10-22 | Katherine M. Clark | sell | $1K – $15K |
| 2020-10-22 | Katherine M. Clark | sell | $1K – $15K |